Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine
Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorized the companies’ XBB.1.5-adapted monovalent COVID-19 ...